Edition:
United Kingdom

People: Avadel Pharmaceuticals PLC (AVDL.OQ)

AVDL.OQ on NASDAQ Stock Exchange Global Market

1.18USD
9:00pm BST
Change (% chg)

$0.03 (+2.61%)
Prev Close
$1.15
Open
$1.15
Day's High
$1.23
Day's Low
$1.10
Volume
37,078
Avg. Vol
41,963
52-wk High
$7.96
52-wk Low
$1.10

Hatten, Sandra 

Ms. Sandra L. Hatten serves as Senior Vice President - Quality and Regulatory Affairs of the Company. Ms. Hatten was appointed Senior Vice President of Quality and Regulatory Affairs of Avadel in June 2015. Prior to joining Avadel, Ms. Hatten was employed from October 2010 to June 2015 by Mallinckrodt, plc, a global specialty biopharmaceutical company, where she served as Senior Vice President of Quality and Regulatory Compliance from February 2014 until June 2015. From October 2010 until September 2012, Ms. Hatten was employed by Mallinckrodt, as Director and Sr. Director of Quality. From September 2012 until February 2014, Ms. Hatten held the position of Vice President, Quality and Regulatory Compliance with Mallinckrodt. Ms. Hatten has more than 30 years of experience in the pharmaceutical industry, during which she has held leadership roles in quality and operations for branded as well as generic drug manufacturers, where she has been responsible for establishing and implementing broad-based quality programs across multiple sites. Ms. Hatten holds bachelor’s and master’s degrees from Marshall University in Huntington, West Virginia.

Basic Compensation

Total Annual Compensation, USD 885,997
Restricted Stock Award, USD 375,800
Long-Term Incentive Plans, USD --
All Other, USD 10,600
Fiscal Year Total, USD 1,272,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --